Literature DB >> 8012771

Treatment of interstitial cystitis with intravesical heparin.

C L Parsons1, T Housley, J D Schmidt, D Lebow.   

Abstract

OBJECTIVE: To control the symptoms of interstitial cystitis with chronic self-administered intravesical heparin and determine whether the drug's continued use can sustain remission. PATIENTS AND METHODS: A total of 48 patients were selected to undergo intravesical heparin therapy, 10,000 units in 10 ml sterile water, three times per week for 3 months. For patients who attained a good clinical remission, therapy was available for up to a further 9 months.
RESULTS: At 3 months 27 of 48 patients (56%) attained good clinical remissions. All were offered continuous therapy and 23 elected for an additional 3 months. Twenty of the 23 continued in remission. Sixteen of these patients elected to have a further 6 months of therapy (12 months total) and 15 of 16 remained in remission.
CONCLUSION: In over half of the patients studied, intravesical heparin controls the symptoms of interstitial cystitis with continued improvement even after one year of therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012771     DOI: 10.1111/j.1464-410x.1994.tb07634.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  35 in total

Review 1.  Interstitial cystitis.

Authors:  D R Erickson; M F Davies
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

Review 2.  Current best practice in the management of cystitis and pelvic pain.

Authors:  Jayne Louise Douglas-Moore; Jonathan Goddard
Journal:  Ther Adv Urol       Date:  2017-10-25

Review 3.  Painful bladder syndrome: an update and review of current management strategies.

Authors:  Anthony J Dyer; Christian O Twiss
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

4.  Treatment approaches for interstitial cystitis: multimodality therapy.

Authors:  Robert J Evans
Journal:  Rev Urol       Date:  2002

5.  Interstitial cystitis and lower urinary tract symptoms in males and females-the combined role of potassium and epithelial dysfunction.

Authors:  C Lowell Parsons
Journal:  Rev Urol       Date:  2002

Review 6.  Resiniferatoxin in the treatment of interstitial cystitis: a systematic review.

Authors:  Eleni G Mourtzoukou; Christos Iavazzo; Matthew E Falagas
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-19

Review 7.  Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis.

Authors:  Sung Ryul Shim; Young Joo Cho; In-Soo Shin; Jae Heon Kim
Journal:  Int Urol Nephrol       Date:  2016-04-30       Impact factor: 2.370

Review 8.  [Urethral pain syndrome: fact or fiction--an update].

Authors:  N M Dreger; S Degener; S Roth; A S Brandt; D A Lazica
Journal:  Urologe A       Date:  2015-09       Impact factor: 0.639

9.  Hyaluronan treatment of interstitial cystitis/painful bladder syndrome.

Authors:  Claus R Riedl; Paul F Engelhardt; Kurosch L Daha; Nike Morakis; Heinz Pflüger
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-12-21

10.  A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.

Authors:  M Cervigni; F Natale; L Nasta; A Padoa; R Lo Voi; D Porru
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.